))
Additional Advances in Myelofibrosis Research and Clinical Trials With John Mascarenhas, MD
Manage episode 357636651 series 3456244
Contenido proporcionado por i3 Health and I3 Health. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente i3 Health and I3 Health o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Myelofibrosis is a rare myeloproliferative neoplasm characterized by the buildup of scar tissue in the bone marrow, leading to decreased erythropoiesis, progressive bone marrow failure, and anemia. Currently, the discovery of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway's role in the pathogenesis of myelofibrosis is transforming the landscape with novel agents that improve patients' outcomes. However, correctly diagnosing and managing this disease using novel therapies and strategies remains challenging for clinicians. To complete the activity and claim free CME/NCPD, visit: https://i3health.com/mf
…
continue reading
44 episodios
Compartir
